Molecular Signature of Multisystem Cardiometabolic Stress and Its Association With Prognosis

Abstract

IMPORTANCE Cardiometabolic disease is responsible for decreased longevity and poorer cardiovascular outcomes in the modern era. Metabolite profiling provides a specific measure of global metabolic function to examine specific metabolic mechanisms and pathways of cardiometabolic disease beyond its clinical definitions.OBJECTIVES To define a molecular basis for cardiometabolic stress and assess its association with cardiovascular prognosis. DESIGN, SETTING, AND PARTICIPANTSA prospective observational cohort study was conducted in a population-based setting across 2 geographically distinct centers (Boston Puerto Rican Health Study [BPRHS], an ongoing study of individuals enrolled between June 1, 2004, and October 31, 2009; and Atherosclerosis Risk in Communities [ARIC] study, whose participants were originally sampled between November 24, 1986, and February 10, 1990, and followed up through December 31, 2017). Participants in the BPRHS were 668 Puerto Rican individuals with metabolite profiling living in Massachusetts, and participants in the ARIC study were 2152 individuals with metabolite profiling and long-term follow-up for mortality and cardiovascular outcomes. Statistical analysis was performed from October 1, 2018, to March 13, 2020. EXPOSURE The primary exposure was metabolite profiles across both cohorts. MAIN OUTCOMES AND MEASURESOutcomes included associations with multisystem cardiometabolic stress and all-cause mortality and incident coronary heart disease (in the ARIC study). RESULTS Participants in the BPRHS (N = 668; 491 women; mean [SD] age, 57.0 [7.4] years; mean [SD] body mass index [calculated as weight in kilograms divided by height in meters squared], 32.0 [6.5]) had higher prevalent cardiometabolic risk relative to those in the ARIC study (N = 2152; 599 African American individuals; 1213 women; mean [SD] age, 54.3 [5.7] years; mean [SD] body mass index, 28.0 [5.5]). Multisystem cardiometabolic stress was defined for 668 Puerto Rican individuals in the BPRHS as a multidimensional composite of hypothalamic-adrenal axis activity, sympathetic activation, blood pressure, proatherogenic dyslipidemia, insulin resistance, visceral adiposity, and inflammation. A total of 260 metabolites associated with cardiometabolic stress were identified in the BPRHS, involving known and novel pathways of cardiometabolic disease (eg, amino acid metabolism, oxidative stress, and inflammation). A parsimonious metabolite-based score associated with cardiometabolic stress in the BPRHS was subsequently created; this score was applied to shared metabolites in the ARIC study, demonstrating significant associations with coronary heart disease and all-cause mortality after multivariable adjustment at a 30-year horizon (per SD increase in metabolomic score: hazard ratio, 1.14; 95% CI, 1.00-1.31; P = .045 for coronary heart disease; and hazard ratio, 1.15; 95% CI, 1.07-1.24; P < .001 for all-cause mortality). CONCLUSIONS AND RELEVANCEMetabolites associated with cardiometabolic stress identified known and novel pathways of car...

Elevated plasma and urinary erythritol is a biomarker of excess simple carbohydrate intake in mice

“…There are several factors that may contribute to the lack of changes in fasting plasma erythritol in mouse models. This work was performed in young, healthy mice, whereas the human observational studies have largely been performed on middle-aged participants (2,3,(5)(6)(7)(8)10). These findings may also reflect species-specific differences in metabolism.…”

“…Serum erythritol is one biomarker with the potential to detect the metabolic dysregulation that precedes cardiometabolic diseases (1). Prospective cohort studies indicate that serum erythritol is elevated decades before the incidence of Type 2 Diabetes Mellitus and cardiovascular disease (2)(3)(4)(5)(6)(7)(8). Elevated erythritol has been consistently identified as a biomarker not only for future disease incidence, but also for worse outcomes in diagnosed patients (9)(10)(11).…”

Roles of Oxidative Stress and Inflammation in Vascular Endothelial Dysfunction-Related Disease

“…Oxidative stress and inflammation play an important role in the development of cardiovascular diseases (CVD) [ 1 , 2 , 3 , 4 , 5 ]. The sources of production of reactive oxygen species (ROS) in blood vessels include nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, xanthine oxidase, uncoupled endothelial nitric oxide synthase (eNOS), arachidonic acid metabolic pathway, mitochondrial electron transfer system dysfunction, and catecholamine autoxidation [ 6 , 7 ].…”

Chronic dietary erythritol exposure elevates fasting plasma erythritol levels but does not cause weight gain or modify glucose homeostasis in mice

“…2 In the larger Atherosclerosis Risk in Communities (ARIC) cohort, serum erythritol was significantly associated with both incident T2DM and cardiovascular disease risk. 3–5 In these studies, non-targeted serum metabolomics were performed on serum collected at baseline and analyzed for association with cardiometabolic disease onset up to 20 years later. Serum erythritol improved prediction of diabetes onset beyond fasting glucose or other known diabetes risk factors.…”